Jacek Kubica

Professor

Nicolaus Copernicus University, Collegium Medicum

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jacek Kubica is a Professor at Nicolaus Copernicus University, Collegium Medicum in Poland. His research primarily focuses on cardiology, particularly in the areas of cardiovascular risk management, lipid disorders, and the impact of COVID-19 on cardiovascular health. His recent publications include studies on the diagnostic value of cardiac troponins, the effectiveness of personalized rehabilitation post-COVID-19, and the management of patients at high cardiovascular risk.

Articles (19)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (15)

Aldona Kubica

Professor

Nicolaus Copernicus University, Collegium Medicum

POLAND

Jacek Kubica

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Rosuvastatin-Based Combination Treatment with Acetylsalicylic Acid or Ezetimibe in the Management of Patients at High and Very High Cardiovascular Risk. Expert Opinion Paper of the Polish Lipid Association 2025.

COVID-19-Related Pathologies in Coronary Angiography in Patients with Acute Coronary Syndromes

Lipoprotein (a) and the Occurrence of Lipid Disorders and Other Cardiovascular Risk Factors in Patients without Diagnosed Cardiovascular Disease

Drug-Eluting Balloons and Drug-Eluting Stents in Diabetic Patients Undergoing Percutaneous Coronary Intervention Due to Restenosis—DM-Dragon Registry

Gender-Related Effectiveness of Personalized Post-COVID-19 Rehabilitation

Achieving Cardiovascular Risk Management Goals and Patient Quality of Life

Sex Differences in Fractional Flow Reserve Utilization

Influence of Sex and Cardiometabolic Risk Factors on the High-Sensitivity Cardiac Troponins at the Concentrations Used as the Thresholds for Cardiovascular Risk Stratification in a Presumably Healthy Polish Population

A Systematic Review and Meta-Analysis of the Diagnostic Value of Galectin-3 in Acute Coronary Syndrome

Determinants of Lipid Parameters in Patients without Diagnosed Cardiovascular Disease—Results of the Polish Arm of the EUROASPIRE V Survey

Comparison of reorganized versus unaltered cardiology departments during the COVID-19 era: a subanalysis of the COV-HF-SIRIO 6 study.

PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection

Pretreatment with P2Y12 Receptor Inhibitors in Acute Coronary Syndromes—Is the Current Standpoint of ESC Experts Sufficiently Supported?

Ion channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The ReCOVery-SIRIO randomized trial.

Pre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022.

Diurnal Oscillations of Fibrinolytic Parameters in Patients with Acute Myocardial Infarction and Their Relation to Platelet Reactivity: Preliminary Insights.

Mild therapeutic hypothermia or targeted temperature management for cardiac arrest survivors?

Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B.

Summary of ESC guidelines on dual antiplatelet therapy in patients after percutaneous coronary interventions.

Collaborators (15)

Aldona Kubica

Marek Koziński

Krzysztof Buczkowski

Filip M. Szymanski

Witold Streb

Eliano Pio Navarese

Maciej Lesiak

Jacek Bil

Joanna Boinska

Łukasz Pietrzykowski

Piotr Jankowski

Pawel Gasior

Marek Gierlotka

Agata Kosobucka

Magdalena Krintus

Make your next move.